PATH Questionnaire Reliability and Validity Study

PATH 问卷信度和效度研究

基本信息

批准号：
9174638
负责人：
ROGER E TOURANGEAU
金额：
$ 83.74万
依托单位：
WESTAT, INC.
依托单位国家：
美国
项目类别：
财政年份：
2016
资助国家：
美国
起止时间：
2016-09-01 至 2018-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9174638
关键词：
Adult Affect Age Alcohol or Other Drugs use Area Attitude Behavior Behavioral Biological Markers Cessation of life Characteristics Computer Assisted Computer software Congresses Contractor Data Data Collection Development Drug usage Education Epidemiology Equation Family Frequencies Future Generations Goals Health Health Food Health Surveys Household Interview Interviewer Investigation Investments Knowledge Length Light Longitudinal Studies Marketing Measurement Medical Memory Mental Health Methods Modeling Monitor National Institute of Drug Abuse Nature Outcome Parents Participant Patient Self-Report Pattern Perception Personality Persons Policies Policy Maker Population Procedures Psychometrics Questionnaires Reporting Research Research Personnel Research Priority Respondent Saliva Sampling Scientific Advances and Accomplishments Smoking Prevention Specialist Specimen Survey Methodology Surveys System Testing Time Tobacco Tobacco use Training United States United States Food and Drug Administration United States National Institutes of Health Validity and Reliability Work Youth authority base cigarette smoking design experience follow-up health data instrument national surveillance programs response statistics study population syntax tobacco control tobacco prevention tool trend young adult

项目摘要

PROJECT SUMMARY/ABSTRACT With a new generation of tobacco products either on the market or being developed, surveillance is critical to describe the changing patterns and correlates of tobacco use in the U.S. population. The Population Assessment of Tobacco and Health (PATH) Study is the first large research effort undertaken by the National Institutes of Health (NIH) and the Food and Drug Administration (FDA). PATH is a national longitudinal study of tobacco use and health that is following approximately 46,000 U.S. household residents ages 12 and older. Westat is the research company leading the development, data collection, and analyses of PATH. Building on systems that are already in place at Westat, this proposal seeks to estimate the test-retest reliability and validity of the PATH questionnaires. A separate reliability and validity study of the PATH adult and youth round four instruments is proposed in which a national sample of 875 respondents will be interviewed in a subsample of the PATH sample areas. Respondents will be interviewed twice, with the re-interview completed within 10 to 17 days after the initial interview. For a subset of the items on which discrepancies are found, the questionnaire will include probes designed to shed light on the nature of the discrepancy. To assess the validity of answers to key items on tobacco use saliva specimens will be analyzed for biomarkers and, at the end of the reinterview, the interviewer will photograph the products used by the participant and they will be compared to the brands self-reported in the questionnaire. Additional methodological enhancements and analyses to broaden the scientific value of the study will be conducted to identify person-level variables associated with differing levels of reliability, identify characteristics of the questions that affect the reliability of the answers, and examine the convergence of different methods for estimating reliabilities. PATH will serve researchers, agencies, and policy makers with the most comprehensive and up-to-date data on the changing tobacco and substance use landscape of any survey to date. It is, thus, crucial to establish the reliability of the PATH data. The proposed team includes experienced survey methodology experts and tobacco control specialists. The project will advance knowledge of person-level predictors of reliable tobacco survey responses as well as characteristics of the survey items themselves that may produce more reliable and valid reporting; these findings will be incorporated in new tools to predict the reliability of survey questions, advancing measurement practices in the study of substance use behaviors.

项目概要/摘要随着新一代烟草产品上市或正在开发，监测对于描述美国人口烟草使用的变化模式和相关性。人口烟草与健康评估 (PATH) 研究是国家烟草管理局开展的第一项大型研究工作卫生研究院 (NIH) 和食品和药物管理局 (FDA)。 PATH 是一项全国纵向研究烟草使用与健康调查对大约 46,000 名 12 岁及以上的美国家庭居民进行了跟踪调查。 Westat 是一家领先 PATH 开发、数据收集和分析的研究公司。建立在系统已经在 Westat 就位，该提案旨在估计重测的可靠性和 PATH 问卷的有效性。 PATH 成人和青少年轮次的单独信度和效度研究提出了四项文书，其中将在子样本中对 875 名受访者进行全国抽样调查 PATH 示例区域的数量。受访者将接受两次访谈，重访将在 10 至 10 天内完成。初次面试后 17 天。对于发现差异的项目子集，调查问卷将包括旨在阐明差异性质的调查。评估将分析有关烟草使用唾液样本的关键项目答案的有效性，以获取生物标志物，并在重访结束时，采访员将对参与者使用的产品进行拍照，并将其记录在案。与问卷中自我报告的品牌进行比较。其他方法论的改进和将进行分析以扩大研究的科学价值，以确定个人层面的变量与不同的可靠性水平相关，确定影响可靠性的问题的特征答案，并检查估计可靠性的不同方法的收敛性。 PATH 将服务研究人员、机构和政策制定者拥有有关变化的最全面和最新的数据迄今为止任何调查的烟草和药物使用情况。因此，确定系统的可靠性至关重要路径数据。拟议的团队包括经验丰富的调查方法专家和烟草控制专家专家。该项目将增进对可靠烟草调查反应的个人预测因素的了解以及调查项目本身的特征，这些特征可能会产生更可靠和有效的报告；这些发现将被纳入新工具中以预测调查问题的可靠性，推进物质使用行为研究中的测量实践。